{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:35:39Z","timestamp":1786325739942,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.neuropharm.2012.11.003","type":"journal-article","created":{"date-parts":[[2012,11,14]],"date-time":"2012-11-14T21:02:24Z","timestamp":1352926944000},"page":"1-7","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of Tuberous Sclerosis Complex"],"prefix":"10.1016","volume":"67","author":[{"given":"Marco","family":"Cambiaghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cursi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Magri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Castoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Minicucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Leocani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neuropharm.2012.11.003_bib1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1179\/1743132812Y.0000000004","article-title":"Chronic application of topiramate and carbamazepine differentially affects the EEG and penicillin-induced epileptiform activity in rats","volume":"34","author":"Aydin-Abidin","year":"2012","journal-title":"Neurol. Res."},{"issue":"7\u20138","key":"10.1016\/j.neuropharm.2012.11.003_bib2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.neuropharm.2009.08.003","article-title":"Acute atomoxetine effects on the EEG of children with attention-deficit\/hyperactivity disorder","volume":"57","author":"Barry","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib3","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/sleep\/29.10.1339","article-title":"Sleep EEG changes after middle cerebral artery infarcts in mice: different effects of striatal and cortical lesions","volume":"29","author":"Baumann","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbr.2008.09.035","article-title":"Increased elevated plus maze open-arm time in mice during spontaneous morphine withdrawal","volume":"197","author":"Buckman","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib6","article-title":"Temporal evolution of neurophysiological and behavioral features of synapsin I\/II\/III triple knock-out mice","author":"Cambiaghi","year":"2012","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0810as55","article-title":"Rodent models of depression: forced swim and tail suspension behavioural despair tests in rats and mice","author":"Castagne","year":"2011","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.brainresbull.2008.03.005","article-title":"Antidepressive-like effects of rapamycin in animal models: implications for mTOR inhibition as a new target for treatment of affective disorders","volume":"76","author":"Cleary","year":"2008","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.neuropharm.2012.11.003_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neurobiolaging.2004.03.004","article-title":"Sleep wake profile and EEG spectral power in young or old senescence accelerated mice","volume":"26","author":"Colas","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib10","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"6","key":"10.1016\/j.neuropharm.2012.11.003_bib11","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.biopsych.2009.12.008","article-title":"Reduced adult neurogenesis and altered emotional behaviors in autoimmune-prone B-cell activating factor transgenic mice","volume":"67","author":"Crupi","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.neuropharm.2012.11.003_bib13","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","article-title":"Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial","volume":"17","author":"Davies","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00787-005-0443-1","article-title":"Consensus clinical guidelines for the assessment of cognitive and behavioural problems in tuberous sclerosis","volume":"14","author":"de Vries","year":"2005","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib15","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/08830738040190090401","article-title":"Brain abnormalities in tuberous sclerosis complex","volume":"19","author":"DiMario","year":"2004","journal-title":"J.\u00a0Child. Neurol."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.molmed.2010.10.002","article-title":"Rapamycin for treating tuberous sclerosis and autism spectrum disorders","volume":"172","author":"Ehninger","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10519-010-9398-1","article-title":"Increased levels of anxiety-related behaviours in a Tsc2 dominant negative transgenic mouse model of tuberous sclerosis","volume":"413","author":"Ehninger","year":"2011","journal-title":"Behav. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","article-title":"Reversal of learning deficits in a Tsc2+\/\u2212 mouse model of Tuberous sclerosis","volume":"14","author":"Ehninger","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib19","article-title":"From genes to cognition in tuberous sclerosis: implications for mTOR inhibitor-based treatment approaches","author":"Ehninger","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib20","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1089\/neu.2010.1370","article-title":"Hippocampal dysfunction after lateral fluid percussion injury","volume":"27","author":"Fedor","year":"2010","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib21","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib22","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.21317","article-title":"Cognitive deficits in Tsc1+\/\u2212 mice in the absence of cerebral lesions and seizures","volume":"62","author":"Goorden","year":"2007","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.neuropharm.2012.11.003_bib23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2125.2011.04104.x","article-title":"The analgesic effect of pregabalin in patients with chronic pain is reflected by changes in pharmaco-EEG spectral indices","volume":"73","author":"Graversen","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1385\/MN:34:3:205","article-title":"The growing role of mTOR in neuronal development and plasticity","volume":"34","author":"Jaworski","year":"2006","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1017\/S0033291702007092","article-title":"Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex","volume":"33","author":"Joinson","year":"2003","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","article-title":"mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery","volume":"110","author":"Kim","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000118911","article-title":"Are there EEG correlates of mental states in animals?","volume":"26","author":"Klemm","year":"1992","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0167-8760(97)00773-3","article-title":"EEG-alpha rhythms and memory processes","volume":"26","author":"Klimesch","year":"1997","journal-title":"Int. J. Psychophysiol."},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2012.11.003_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-0173(98)00056-3","article-title":"EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis","volume":"29","author":"Klimesch","year":"1999","journal-title":"Brain Res. Cogn. Brain Res. Rev."},{"issue":"3","key":"10.1016\/j.neuropharm.2012.11.003_bib30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000119015","article-title":"Classification of psychotropic drugs based on pharmaco-electrocorticographic studies in vigilance-controlled rats","volume":"28","author":"Krijzer","year":"1993","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib31","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.neuropharm.2012.11.003_bib32","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/jnnp.69.2.192","article-title":"Electroencephalographic coherence analysis in multiple sclerosis: correlation with clinical, neuropsychological, and MRI findings","volume":"69","author":"Leocani","year":"2000","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatr."},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2012.11.003_bib33","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1007\/s10072-010-0398-y","article-title":"Neurophysiological correlates of\u00a0cognitive disturbances in multiple sclerosis","volume":"31","author":"Leocani","year":"2010","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuropharm.2004.03.017","article-title":"Effects of diazepam and zolpidem on EEG beta frequencies are behaviour-specific in rats","volume":"47","author":"van Lier","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib35","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1097-2765(02)00636-6","article-title":"Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control","volume":"10","author":"Loewith","year":"2002","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib36","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.stem.2011.09.008","article-title":"Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions","volume":"9","author":"Magri","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1528-1167.2008.01814.x","article-title":"Are cortical tubers epileptogenic? Evidence from electrocorticography","volume":"50","author":"Major","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib38","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bbr.2007.09.005","article-title":"Effects of chronic social stress in adolescence on anxiety and neuroendocrine response to mild stress in male and female rats","volume":"187","author":"McCormick","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib39","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1523\/JNEUROSCI.5540-06.2007","article-title":"A\u00a0mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival","volume":"27","author":"Meikle","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib40","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin mTOR inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function","volume":"28","author":"Meikle","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib41","first-page":"2","article-title":"Exaggerated aggression and decreased anxiety in mice deficient in brain serotonin","volume":"29","author":"Mosienko","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib42","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.yebeh.2007.07.010","article-title":"Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex","volume":"114","author":"Muzykewicz","year":"2007","journal-title":"Epilepsy Behav."},{"issue":"12","key":"10.1016\/j.neuropharm.2012.11.003_bib43","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1038\/npp.2011.142","article-title":"Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: neural and behavioral consequences","volume":"36","author":"Narboux-N\u00eame","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib44","article-title":"Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats","author":"P\u00e1len\u00ed\u010dek","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"17","key":"10.1016\/j.neuropharm.2012.11.003_bib45","doi-asserted-by":"crossref","first-page":"7695","DOI":"10.1523\/JNEUROSCI.22-17-07695.2002","article-title":"Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control","volume":"22","author":"Parmentier","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib46","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"issue":"11","key":"10.1016\/j.neuropharm.2012.11.003_bib47","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/BF01950020","article-title":"Arousal deficit shown in aged rat's quantitative EEG and ameliorative action of pramiracetam compared to piracetam","volume":"41","author":"Poschel","year":"1985","journal-title":"Experientia"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0092-8674(94)90570-3","article-title":"RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs","volume":"78","author":"Sabatini","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib49","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.yebeh.2004.07.011","article-title":"Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers","volume":"5","author":"Salinsky","year":"2004","journal-title":"Epilepsy Behav."},{"issue":"10","key":"10.1016\/j.neuropharm.2012.11.003_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003301","article-title":"Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants","volume":"3","author":"Savelieva","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib51","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/nn1566","article-title":"Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2","volume":"8","author":"Tavazoie","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.10283","article-title":"Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures","volume":"52","author":"Uhlmann","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib53","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.molmed.2007.06.003","article-title":"The tuberous sclerosis complex proteins \u2013 a GRIPP on cognition and neurodevelopment","volume":"13","author":"de Vries","year":"2007","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2012.11.003_bib54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMc062928","article-title":"The tuberous sclerosis complex","volume":"356","author":"de Vries","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/ajmg.a.32690","article-title":"Neuropsychological attention deficits in tuberous sclerosis complex TSC","volume":"149A","author":"de Vries","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib56","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/hmg\/ddp025","article-title":"Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse","volume":"18","author":"Way","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib57","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0149-7634(98)00027-X","article-title":"Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety","volume":"23","author":"Weiss","year":"1998","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib58","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1109\/TAU.1967.1161901","article-title":"The use of fast Fourier transform for the estimation of power spectra: a method based on time averaging over short, modified periodograms","volume":"AU-15","author":"Welch","year":"1967","journal-title":"IEEE Trans. Audio Electroacoustics"},{"key":"10.1016\/j.neuropharm.2012.11.003_bib59","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2012.11.003_bib60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","article-title":"mTOR: from growth signal integration to cancer, diabetes and ageing","volume":"12","author":"Zoncu","year":"2011","journal-title":"Nat. Rev. Mol. Cell. Biol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812005370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812005370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T16:48:55Z","timestamp":1562345335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812005370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":60,"alternative-id":["S0028390812005370"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.11.003","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}